v3.26.1
REVENUES
 6 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
REVENUES REVENUES
The Company’s Revenues by segment and by payer group were as follows:
Three Months Ended June 30, 2026Three Months Ended June 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients22 %— %— %22 %24 %— %— %24 %
   Patients11 %— %— %11 %10 %— %— %10 %
   Medicare and Medicaid8 %— %— %8 %8 %— %— %8 %
   Third party37 %— %— %37 %36 %— %— %36 %
Total Dx revenues78 %— %— %78 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs9 %9 %4 %22 %9 %9 %4 %22 %
Total Revenues
87 %9 %4 %100 %87 %9 %4 %100 %
Six Months Ended June 30, 2026Six Months Ended June 30, 2025
North AmericaEuropeOtherTotalNorth AmericaEuropeOtherTotal
Dx:
   Clients23 %— %— %23 %24 %— %— %24 %
   Patients10 %— %— %10 %10 %— %— %10 %
   Medicare and Medicaid8 %— %— %8 %8 %— %— %8 %
   Third party37 %— %— %37 %36 %— %— %36 %
Total Dx revenues78 %— %— %78 %78 %— %— %78 %
BLS:
Pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs8 %10 %4 %22 %9 %9 %4 %22 %
Total Revenues86 %10 %4 %100 %87 %9 %4 %100 %
Revenues in the U.S. were $3,095.5 (83.0%) and $2,931.6 (83.1%) for the three months ended June 30, 2026, and 2025, respectively, and were $6,009.5 (82.7%) and $5,745.4 (83.6%) for the six months ended June 30, 2026, and 2025, respectively.
Accounts Receivable, Unbilled Services, and Unearned Revenue
The following table provides information about accounts receivable and unbilled services from contracts with customers:
June 30, 2026December 31, 2025
Dx accounts receivable$1,546.6 $1,349.0 
BLS accounts receivable833.0 791.2 
Less: BLS allowance for credit losses(37.2)(36.4)
Accounts receivable, net$2,342.4 $2,103.8 
Gross unbilled services$165.9 $164.0 
Less: BLS allowance for credit losses(3.5)(7.1)
Unbilled services, net$162.4 $156.9 
Revenues recognized during the period that were included in the unearned revenue balance at the beginning of the period were $34.1 and $34.4 for the three months ended June 30, 2026, and 2025, respectively, and were $92.4 and $103.3 for the six months ended June 30, 2026, and 2025, respectively.
Allowance for Credit Losses
BLS estimates future expected credit losses on Accounts receivable, net and Unbilled services, net over the remaining collection period of the underlying asset. The rollforward for the allowance for credit losses was as follows:
Accounts Receivable, netUnbilled Services, netTotal
Allowance for credit losses at December 31, 2025
$36.4 $7.1 $43.5 
Credit loss expense4.9 — 4.9 
Write-offs(3.8)(3.6)(7.4)
Foreign currency impact
(0.3)— (0.3)
Allowance for credit losses at June 30, 2026$37.2 $3.5 $40.7